Shorts: Samsung’s $1B health investment

By: Brian Dolan | May 17, 2010        

Tags: | | | | |  |

Samsung’s $1B health investment: The second largest mobile phone manufacturer in the world, South Korea-based Samsung announced this week that it plans to invest about $20 billion in healthcare and green energy through 2020. That includes about $1 billion to develop and make electronic healthcare equipment. More

ZigBee certifies Freescale: Freescale Semiconductor today announced it has received ZigBee® Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services. A recent report by ON World, “WSN for Health Care,” estimates that wireless sensor networks can reduce annual health care costs by $25 billion (US) by 2012. More

mHealth delivers RX for change: According to a report from Wireless Week, the West Wireless Health Institute plans to establish an office in Washington, D.C. The WW report includes some quotes from Verizon Wireless’ John Maschenic as well more about GE’s new partnership with the WWHI. More

Controversial mobile phone linked to tumors study: Results from the largest, longest and arguably most controversial study on whether mobile phones increase the risk of brain cancer in users became even more controversial when news media broke the embargo for the study results and published them ahead of time. More

Pepid goes Android: Pepid launched its mobile app for Android devices. According to the company, Pepid is now available on “every major” smartphone platform, including Android, iPhone, BlackBerry, Windows Mobile and Palm Pre. More

  • http://wellescent.com/health_forum/topics Wellescent Health Forums

    With a large quantity of the population soon to be retired, it seems like the market for mobile health products will be quite large for both personal use and the use by doctors increasing. The question is whether the market is really based on extensions of a ubiquitous platform like the iPhone or on custom mobile devices. I would more likely suspect the common platforms will have the upper hand in this context due to their more general availability and usage.